-
-
-
-
-
-
-
LIXTE expands ovarian cancer trial to 42 patients
-
-
-
-
-
-
-
LIXTE Biotechnology announces leadership changes and $5 million funding
-
-
-
-
-
-
-
Lixte Biotechnology Holdings, Inc. (LIXT) files to withdraw offering
-
-
-
-
408,875 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

